• 1. Aggregation-induced emission enhancement of carbon quantum dots and applications in light emitting devices
  Rongyan Guo,Tao Li,Shuie Shi J. Mater. Chem. C, 2019,7, 5148-5154
• 2. Achieving high-efficiency purely organic room-temperature phosphorescence materials by boronic ester substitution of phenoxathiine?
  Mengke Li,Xinyi Cai,Zhenyang Qiao,Wentao Xie,Liangying Wang,Nan Zheng,Shi-Jian Su Chem. Commun., 2019,55, 7215-7218
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 5. An ionic liquid-mesoporous silica blend as a novel adsorbent for the adsorption and recovery of palladium ions, and its applications in continuous flow study and as an industrial catalyst?
  Shivani Sharma,Chia-Ming Wu,Ranjit T. Koodali,N. Rajesh RSC Adv., 2016,6, 26668-26678

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Introduction to 2-(2-Fluoropyrimidin-5-yl)acetonitrile (CAS No. 1000558-17-7)

2-(2-Fluoropyrimidin-5-yl)acetonitrile, with the CAS number 1000558-17-7, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a fluorinated pyrimidine ring and an acetonitrile group. These structural elements contribute to its potential applications in the development of novel therapeutic agents, particularly in the areas of oncology and antiviral research.

The chemical structure of 2-(2-Fluoropyrimidin-5-yl)acetonitrile can be represented as C₇H₄FN₃. The presence of the fluorine atom in the pyrimidine ring imparts unique electronic and steric properties, which can influence the compound's biological activity and pharmacokinetic profile. The acetonitrile group, on the other hand, can serve as a bioisostere for carboxylic acid, providing a means to modulate the physicochemical properties of the molecule without significantly altering its biological activity.

In recent years, 2-(2-Fluoropyrimidin-5-yl)acetonitrile has been extensively studied for its potential as a lead compound in drug discovery. One of the key areas of interest is its use as an inhibitor of specific enzymes involved in cancer cell proliferation. For instance, research has shown that derivatives of this compound can effectively inhibit the activity of kinases such as Abl and Src, which are known to play crucial roles in various signaling pathways associated with cancer progression.

Beyond oncology, 2-(2-Fluoropyrimidin-5-yl)acetonitrile has also shown promise in antiviral applications. Studies have demonstrated that certain derivatives of this compound exhibit potent antiviral activity against a range of viruses, including influenza and HIV. The mechanism of action is thought to involve the inhibition of viral replication enzymes, such as RNA-dependent RNA polymerase (RdRp), which is essential for viral genome replication.

The synthesis of 2-(2-Fluoropyrimidin-5-yl)acetonitrile typically involves a multi-step process that includes the formation of the fluorinated pyrimidine ring followed by the introduction of the acetonitrile group. Various synthetic routes have been reported in the literature, each with its own advantages and limitations. For example, one common approach involves the reaction of 2-fluoropyrimidine with an appropriate nitrile precursor under suitable conditions.

In terms of safety and handling, it is important to note that while 2-(2-Fluoropyrimidin-5-yl)acetonitrile is not classified as a hazardous substance, it should still be handled with care in a well-controlled laboratory environment. Proper personal protective equipment (PPE) should be used to minimize exposure risks.

The future prospects for 2-(2-Fluoropyrimidin-5-yl)acetonitrile are promising. Ongoing research continues to explore its potential as a lead compound for developing new drugs targeting various diseases. Additionally, efforts are being made to optimize its pharmacological properties through structure-based drug design and combinatorial chemistry approaches.

In conclusion, 2-(2-Fluoropyrimidin-5-yl)acetonitrile (CAS No. 1000558-17-7) is a valuable compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and diverse biological activities make it an attractive candidate for further investigation and development into novel therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)